Cycloheptyl CP 55,940

CHP-CP55940_structure.png

Cycloheptyl CP 55,940 is a synthetic cannabinoid compound that is structurally related to CP 55,940. It is known for its high affinity for the cannabinoid receptors, particularly CB1 and CB2 receptors, which are part of the endocannabinoid system.

Chemical Structure and Properties

Cycloheptyl CP 55,940 is a derivative of CP 55,940, with a cycloheptyl group replacing the cyclohexyl group. This modification affects its binding affinity and pharmacological properties. The compound is typically studied in the context of neuropharmacology and medicinal chemistry.

Pharmacology

Cycloheptyl CP 55,940 acts as a potent agonist at both CB1 and CB2 receptors. These receptors are involved in various physiological processes, including pain modulation, appetite regulation, and immune response. The compound's high affinity for these receptors makes it a valuable tool in cannabinoid research.

Research Applications

Cycloheptyl CP 55,940 is primarily used in scientific research to study the effects of cannabinoid receptor activation. It helps in understanding the role of the endocannabinoid system in health and disease. Research involving this compound can contribute to the development of new therapeutic agents for conditions such as chronic pain, inflammation, and neurological disorders.

Safety and Legal Status

As a synthetic cannabinoid, Cycloheptyl CP 55,940 is subject to regulatory controls in many jurisdictions. Its use is typically restricted to research settings, and it is not approved for medical use in humans. The safety profile of this compound is not well-established, and it should be handled with caution in laboratory environments.

See Also

• CP 55,940
• Cannabinoid receptor
• Endocannabinoid system
• Synthetic cannabinoids